Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | FDPS | P14324 | 2/20 | 0.33 |
| ▸ | TOP2A | P11388 | 1/20 | 0.33 |
| ▸ | TOP2B | Q02880 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.32 |
| ▸ | KCNA5 | P22460 | 4/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.32 |
| ▸ | KCNE1 | P15382 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19286390 | 0.96 | SMN1; SMN2 (0.43) | SMN1; SMN2FDPSTOP2ATOP2BALDH1A1 | |
| SCHEMBL16687884 | 0.96 | SMN1; SMN2 (0.43) | SMN1; SMN2FDPSTOP2ATOP2BALDH1A1 | |
| SCHEMBL21202593 | 0.96 | SMN1; SMN2 (0.39) | SMN1; SMN2FDPSTOP2ATOP2BALDH1A1 | |
| SCHEMBL23483378 | 0.93 | SMN1; SMN2 (0.42) | SMN1; SMN2FDPSTOP2ATOP2BALDH1A1 | |
| SCHEMBL12257624 | 0.86 | SMN1; SMN2 (0.38) | SMN1; SMN2FDPS | |
| SCHEMBL13256071 | 0.86 | SMN1; SMN2 (0.38) | SMN1; SMN2FDPS | |
| SCHEMBL13417351 | 0.86 | SMN1; SMN2 (0.38) | SMN1; SMN2FDPS | |
| SCHEMBL24928122 | 0.83 | SMN1; SMN2 (0.41) | SMN1; SMN2FDPSALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL20376044 | 0.83 | SMN1; SMN2 (0.41) | SMN1; SMN2FDPSALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL23733535 | 0.83 | SMN1; SMN2 (0.41) | SMN1; SMN2FDPSALDH1A1CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250084045-A1 | PROCESS FOR THE PRODUCTION OF BIS(PYRROLIDINO)BUTANE IN THE LIQUID PHASE | BASF SE (DE) | 2025-03-13 | — | — | US | disclosed |
| EP-4412992-A1 | PROCESS FOR THE PRODUCTION OF BIS(PYRROLIDINO)BUTANE IN THE LIQUID PHASE | BASF SE (DE) | 2024-08-14 | — | — | EP | disclosed |
| EP-4412992-A1 | PROCESS FOR THE PRODUCTION OF BIS(PYRROLIDINO)BUTANE IN THE LIQUID PHASE | BASF SE (DE) | 2024-08-14 | — | — | EP | disclosed |
| WO-2023057358-A1 | PROCESS FOR THE PRODUCTION OF BIS(PYRROLIDINO)BUTANE IN THE LIQUID PHASE | BASF SE (DE) | 2023-04-13 | — | — | WO | disclosed |
| WO-2023057358-A1 | PROCESS FOR THE PRODUCTION OF BIS(PYRROLIDINO)BUTANE IN THE LIQUID PHASE | BASF SE (DE) | 2023-04-13 | — | — | WO | disclosed |
| WO-2023046330-A1 | CONTINUOUS PROCESS FOR THE SEPARATION OF A MIXTURE COMPRISING PYRROLIDINE, BIS(PYRROLIDINO)BUTANE AND WATER | BASF SE (DE) | 2023-03-30 | — | — | WO | disclosed |
| US-11572509-B2 | Ionic liquids formulation as an environmentally friendly oil dispersant | PETROLIAM NASIONAL BERHAD (MY) | 2023-02-07 | — | — | US | disclosed |
| US-20220032249-A1 | IONIC LIQUIDS FORMULATION AS AN ENVIRONMENTALLY FRIENDLY OIL DISPERSANT | PETROLIAM NASIONAL BERHAD (MY) | 2022-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250084045-A1 | PROCESS FOR THE PRODUCTION OF BIS(PYRROLIDINO)BUTANE IN THE LIQUID PHASE | BBOX1, PPOX, POLB | SMN1; SMN2 4620/4885FDPS 223/4885TOP2A 1408/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.